Z-2177-2017 Class II Terminated
FDA device recall Z-2177-2017 was initiated by AbbVie Inc. on Apr 27, 2017 and is designated Class II. Reason for recall: PEG kits have the potential for one of the following defects: missing components, duplicate components or missing label/Instructions for Use, which includes expiry information. The recall status is terminated (terminated Jul 9, 2019).
Recall details
- Product Type
- Devices
- Report Date
- Jun 7, 2017
- Initiation Date
- Apr 27, 2017
- Termination Date
- Jul 9, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Reason for recall
Distribution pattern
Nationwide, Albania, Austria, Australia, Belgium, Bulgaria, Canada, Switzerland, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, Great Britain, Greece, Croatia, Hungary, Ireland, Italy, Japan, Korea, Luxembourg, Netherlands, Norway, Portugal, Romania, Russia, Saudi Arabia, Sweden, Slovenia, Slovakia, Turkey
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2177-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026